Mesothelioma Cancer Resources Blog
-
Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Meso
Rationale After removal of visible cancer in the chest, chemotherapy drugs are used to kill or stop tumor cells from dividing, so that they stop growing or/and die. Cisplatin is currently used safely as in intra-operative treatment for malignant pleural mesothelioma. This study is aimed to determine if the addition of gemcitabine as a second …
Label: Clinical Trial
Posted on Saturday, Mar 1, 2008 -
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
Last Updated: January 21, 2008 Clinical Trial Phase: Phase 2 Start Date: December 2006 Overall Status: Recruiting Estimated Enrollment: 30 Condition Keyword(s): Non-Small Cell Lung Cancer Mesothelioma Lung Neoplasms Intervention(s): Drug: pemetrexed Rationale This study will test the effects of pemetrexed on mesothelioma and lung cancer patients with fluid around their lungs or abdomen. Study …
Label: Clinical Trial
Posted on Saturday, Mar 1, 2008 -
Dendritic Cell-Based Immunotherapy in Mesothelioma
Exploiting the immunostimulatory capacities of dendritic cells holds great promise for cancer immunotherapy. A mouse model for malignant mesothelioma allowed us to prove that autologous dendritic cells presenting tumor antigens were very effective by (partly) inhibiting tumor growth. This study will test the feasibility and safety of a clinical trial using autologous DC as a …
Label: Clinical Trial
Posted on Saturday, Mar 1, 2008
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.